Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer
Oncotarget - United States
doi 10.18632/oncotarget.3106
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 20, 2015
Authors
Publisher
Impact Journals, LLC